An association between amino acid position 74 of HLA-DRB1 and anti-citrullinated protein antibody levels in Japanese patients with anti-citrullinated protein antibody-positive rheumatoid arthritis

Arthritis and Rheumatology

Volumn 67, Issue 8, 2015, Pages 2038-2045

  Terao, Chikashi ^a   Suzuki, Akari ^b   Ikari, Katsunori ^c   Kochi, Yuta ^b   Ohmura, Koichiro ^a   Katayama, Masaki ^a   Nakabo, Shuichiro ^a   Yamamoto, Natsuki ^a   Suzuki, Taku ^c   Iwamoto, Takuji ^c   Yurugi, Kimiko ^d   Miura, Yasuo ^d   Maekawa, Taira ^d   Takasugi, Kiyoshi ^e   Kubo, Michiaki ^b   Saji, Hiroh ^f   Taniguchi, Atsuo ^c   Momohara, Shigeki ^c   Yamamoto, Kazuhiko ^g   Yamanaka, Hisashi ^c   Mimori, Tsuneyo ^a   Matsuda, Fumihiko ^a,h   more..

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b RIKEN   (Japan)

^c TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^d KYOTO UNIVERSITY HOSPITAL   (Japan)

^e Dohgo Spa Hospital   (Japan)

^f Japanese Red Cross Kanto Koshinetsu Block Blood Center   (Japan)

^g UNIVERSITY OF TOKYO   (Japan)

^h JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; AMINO ACID; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; HLA DRB1 ANTIGEN; AUTOANTIBODY; CYCLIC CITRULLINATED PEPTIDE; CYCLOPEPTIDE; HLA DR ANTIGEN; HLA-DR15 ANTIGEN; HLA-DRB1*09:01 ANTIGEN;

ALLELE; AMINO ACID SEQUENCE; ANTIBODY BLOOD LEVEL; ARTICLE; CONCENTRATION (PARAMETERS); CORRELATIONAL STUDY; GENOTYPE; HUMAN; JAPANESE (PEOPLE); MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETICS; IMMUNOLOGY; MALE; METABOLISM; MIDDLE AGED;

ADULT; AGED; ARTHRITIS, RHEUMATOID; ASIAN CONTINENTAL ANCESTRY GROUP; AUTOANTIBODIES; FEMALE; GENOTYPE; HLA-DR SEROLOGICAL SUBTYPES; HLA-DRB1 CHAINS; HUMANS; MALE; MIDDLE AGED; PEPTIDES, CYCLIC;

EID: 84938061120     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.39133     Document Type: Article

References (33)

1. MacGregor AJ, Snieder H, Rigby AS, Koskenvuo M, Kaprio J, Aho K, et al., Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum 2000; 43: 30-7.
2. Deighton CM, Walker DJ, Griffiths ID, Roberts DF., The contribution of HLA to rheumatoid arthritis. Clin Genet 1989; 36: 178-82.
3. Terao C, Ohmura K, Katayama M, Takahashi M, Kokubo M, Diop G, et al., Myelin basic protein as a novel genetic risk factor in rheumatoid arthritis-a genome-wide study combined with immunological analyses. PLoS One 2011; 6: e20457.
4. Terao C, Yamada R, Ohmura K, Takahashi M, Kawaguchi T, Kochi Y, et al., The human AIRE gene at chromosome 21q22 is a genetic determinant for the predisposition to rheumatoid arthritis in Japanese population. Hum Mol Genet 2011; 20: 2680-5.
5. Kroot EJ, de Jong BA, van Leeuwen MA, Swinkels H, van den Hoogen FH, van 't Hof M, et al., The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis. Arthritis Rheum 2000; 43: 1831-5.
6. Schellekens GA, Visser H, de Jong BA, van den Hoogen FH, Hazes JM, Breedveld FC, et al., The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 2000; 43: 155-63.
7. Mackie SL, Taylor JC, Martin SG, YEAR Consortium, UKRAG Consortium, Wordsworth P, et al., A spectrum of susceptibility to rheumatoid arthritis within HLA-DRB1: stratification by autoantibody status in a large UK population. Genes Immun 2012; 13: 120-8.
8. Ohmura K, Terao C, Maruya E, Katayama M, Matoba K, Shimada K, et al., Anti-citrullinated peptide antibody-negative RA is a genetically distinct subset: a definitive study using only bone-erosive ACPA-negative rheumatoid arthritis. Rheumatology (Oxford) 2010; 49: 2298-304.
9. Van der Woude D, Lie BA, Lundstrom E, Balsa A, Feitsma AL, Houwing-Duistermaat JJ, et al., Protection against anti-citrullinated protein antibody-positive rheumatoid arthritis is predominantly associated with HLA-DRB1 1301: a meta-analysis of HLA-DRB1 associations with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in four European populations. Arthritis Rheum 2010; 62: 1236-45.
10. Terao C, Ohmura K, Kochi Y, Ikari K, Maruya E, Katayama M, et al., A large-scale association study identified multiple HLA-DRB1 alleles associated with ACPA-negative rheumatoid arthritis in Japanese subjects. Ann Rheum Dis 2011; 70: 2134-9.
11. Terao C, Ohmura K, Ikari K, Kochi Y, Maruya E, Katayama M, et al., ACPA-negative RA consists of two genetically distinct subsets based on RF positivity in Japanese. PLoS One 2012; 7: e40067.
12. Gregersen PK, Silver J, Winchester RJ., The shared epitope hypothesis: an approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987; 30: 1205-13.
13. Raychaudhuri S, Sandor C, Stahl EA, Freudenberg J, Lee HS, Jia X, et al., Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis. Nat Genet 2012; 44: 291-6.
14. Han B, Diogo D, Eyre S, Kallberg H, Zhernakova A, Bowes J, et al., Fine mapping seronegative and seropositive rheumatoid arthritis to shared and distinct HLA alleles by adjusting for the effects of heterogeneity. Am J Hum Genet 2014; 94: 522-32.
15. Okada Y, Kim K, Han B, Pillai NE, Ong RT, Saw WY, et al., Risk for ACPA-positive rheumatoid arthritis is driven by shared HLA amino acid polymorphisms in Asian and European populations. Hum Mol Genet 2014; 23: 6916-26.
16. Okada Y, Suzuki A, Yamada R, Kochi Y, Shimane K, Myouzen K, et al., HLA-DRB1 0901 lowers anti-cyclic citrullinated peptide antibody levels in Japanese patients with rheumatoid arthritis. Ann Rheum Dis 2010; 69: 1569-70.
17. Terao C, Ikari K, Ohmura K, Suzuki T, Iwamoto T, Takasugi K, et al., Quantitative effect of HLA-DRB1 alleles to ACPA levels in Japanese rheumatoid arthritis: no strong genetic impact of shared epitope to ACPA levels after stratification of HLA-DRB1 09:01. Ann Rheum Dis 2012; 71: 1095-7.
18. Laki J, Lundstrom E, Snir O, Ronnelid J, Ganji I, Catrina AI, et al., Very high levels of anti-citrullinated protein antibodies are associated with HLA-DRB1 15 non-shared epitope allele in patients with rheumatoid arthritis. Arthritis Rheum 2012; 64: 2078-84.
19. Cui J, Taylor KE, Destefano AL, Criswell LA, Izmailova ES, Parker A, et al., Genome-wide association study of determinants of anti-cyclic citrullinated peptide antibody titer in adults with rheumatoid arthritis. Mol Med 2009; 15: 136-43.
20. Irigoyen P, Lee AT, Wener MH, Li W, Kern M, Batliwalla F, et al., Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: contrasting effects of HLA-DR3 and the shared epitope alleles. Arthritis Rheum 2005; 52: 3813-8.
21. Gardette A, Ottaviani S, Tubach F, Roy C, Nicaise-Roland P, Palazzo E, et al., High anti-CCP antibody titres predict good response to rituximab in patients with active rheumatoid arthritis. Joint Bone Spine 2014; 81: 416-20.
22. Bizzaro N, Bartoloni E, Morozzi G, Manganelli S, Riccieri V, Sabatini P, et al., Anti-cyclic citrullinated peptide antibody titer predicts time to rheumatoid arthritis onset in patients with undifferentiated arthritis: results from a 2-year prospective study. Arthritis Res Ther 2013; 15: R16.
23. Kuhn KA, Kulik L, Tomooka B, Braschler KJ, Arend WP, Robinson WH, et al., Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis. J Clin Invest 2006; 116: 961-73.
24. Hill JA, Bell DA, Brintnell W, Yue D, Wehrli B, Jevnikar AM, et al., Arthritis induced by posttranslationally modified (citrullinated) fibrinogen in DR4-IE transgenic mice. J Exp Med 2008; 205: 967-79.
25. Matsuda Y, Singh G, Yamanaka H, Tanaka E, Urano W, Taniguchi A, et al., Validation of a Japanese version of the Stanford Health Assessment Questionnaire in 3,763 patients with rheumatoid arthritis. Arthritis Rheum 2003; 49: 784-8.
26. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al., The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
27. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO III, et al., 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010; 62: 2569-81.
28. Robinson J, Waller MJ, Parham P, de Groot N, Bontrop R, Kennedy LJ, et al., IMGT/HLA and IMGT/MHC: sequence databases for the study of the major histocompatibility complex. Nucleic Acids Res 2003; 31: 311-4.
29. Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, et al., UCSF Chimera-a visualization system for exploratory research and analysis. J Comput Chem 2004; 25: 1605-12.
30. Terao C, Yoshifuji H, Ohmura K, Murakami K, Kawabata D, Yurugi K, et al., Association of Takayasu arteritis with HLA-B 67:01 and two amino acids in HLA-B protein. Rheumatology (Oxford) 2013; 52: 1769-74.
31. Burnham KP, Anderson DR., Model selection and multimodel inference: a practical information-theoretic approach. 2nd ed. New York: Springer; 2002.
32. 67,74 with rheumatoid arthritis and citrullinated vimentin binding [published erratum appears in Arthritis Rheum 2014;66:1671]. Arthritis Rheum 2011; 63: 3733-9.
33. Lundberg K, Bengtsson C, Kharlamova N, Reed E, Jiang X, Kallberg H, et al., Genetic and environmental determinants for disease risk in subsets of rheumatoid arthritis defined by the anticitrullinated protein/peptide antibody fine specificity profile. Ann Rheum Dis 2013; 72: 652-8.